i
Superseded
This Document Has Been Replaced By:
i
Retired
This Document Has Been Retired
i
Up-to-date Information
This is the latest update:
A Public Health Approach to the Prevention of Inhibitors in Hemophilia
-
Published Date:
Sep 19 2014
-
Source:Am J Prev Med. 47(5):669-673.
-
Language:English
-
Details:
-
Alternative Title:Am J Prev Med
-
Personal Author:
-
Description:The development of an antibody in people with hemophilia to products used in the treatment and prevention of bleeding, also referred to as an inhibitor, is the most serious complication of hemophilia care today. CDC, together with healthcare providers, consumer organizations, hemophilia organizations, and federal partners, has developed a public health agenda to prevent the development of inhibitors. This paper describes a public health approach that combines a national surveillance program with epidemiologic, laboratory, and prevention research to address knowledge gaps in rates and risk factors for inhibitor development, and in knowledge and behaviors of patients and providers, in addition to screening and treatment practices.
-
Subject:
-
Pubmed ID:25245801
-
Pubmed Central ID:PMC4469363
-
Document Type:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
- File Type:
-
Supporting Files:
text/xml
No Related Documents.